Zinc sulfate and Restasis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zinc sulfate (zinc sulfate) and Restasis (cyclosporine). Common drug interactions include hyperlipidaemia among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Zinc sulfate and Restasis. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Zinc sulfate?

Zinc sulfate has active ingredients of zinc sulfate. It is often used in zinc deficiency. eHealthMe is studying from 3,216 Zinc sulfate users. Check the latest studies of Zinc sulfate.

What is Restasis?

Restasis has active ingredients of cyclosporine. It is often used in dry eyes. eHealthMe is studying from 35,199 Restasis users. Check the latest studies of Restasis.

On Jul, 30, 2026

18 people who take Zinc sulfate and Restasis together, and have interactions are studied.

Zinc sulfate and Restasis drug interactions.

What are the common drug interactions of Zinc Sulfate and Restasis, by gender? *:

female:

Hyperlipidaemia (presence of excess lipids in the blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
Infusion site pain
Insomnia (sleeplessness)
Lip blister
Localised oedema (fluid retention in a particular part of the body)
Mood swings (an extreme or rapid change in mood)
Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Ovarian cyst (fluid filled sac of the ovary)

male:

Rash
Abnormal sensation in eye
Gait disturbance
Ill-defined disorder
Injection site abscess
Injection site cellulitis (injection site inflammation)
Injection site erythema (redness at injection site)
Injection site pain
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Onychomadesis (a periodic idiopathic shedding of the nails)

What are the common drug interactions of Zinc Sulfate and Restasis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
Anxiety
Aphthous ulcer (mouth ulcer)
Blindness transient (sudden loss of vision)
Blood pressure increased
Dyslexia (disorders that involve difficulty in learning to read or interpret words, letters, and other symbols)
Endometriosis (appearance of endometrial tissue outside the uterus and causing pelvic pain)
Headache (pain in head)
Hot flush (sudden feelings of heat)
Insomnia (sleeplessness)

40-49:

n/a

50-59:

Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
Pain
Rash
Abdominal discomfort
Abdominal pain
Adverse reaction
Anaphylactic reaction (serious allergic reaction)
Appetite disorder (abnormal eating habits)
Arthralgia (joint pain)
Asthenia (weakness)

60+:

Abnormal sensation in eye
Blood glucose increased
Abdominal distension
Acute respiratory failure
Ascites (accumulation of fluid in the abdominal cavity)
Bacteraemia (presence of bacteria in the blood)
Blood albumin decreased
Cardiac failure congestive
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Crest syndrome (thick, dry and fibrous skin)

What are the existing conditions these people have? *

Pain: 5 people, 27.78%
Menopause (end of monthly cycles in women): 3 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 16.67%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 11.11%
Muscle Spasms (muscle contraction): 2 people, 11.11%
Diabetes: 2 people, 11.11%
Itching: 2 people, 11.11%
Lacrimation Increased: 2 people, 11.11%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.11%
Colitis (inflammation of colon): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Zinc sulfate and Restasis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously